ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DRUG Bright Minds Biosciences Inc

54.11
0.00 (0.00%)
17 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bright Minds Biosciences Inc CSE:DRUG CSE Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 54.11 52.49 55.00 96 22:00:00

Dragon announces Date set for 2006 Annual Stockholder Meeting

10/04/2006 2:00pm

PR Newswire (US)


Bright Minds Biosciences (CSE:DRUG)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more Bright Minds Biosciences Charts.
VANCOUVER, April 10 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (OTC BB: DRUG; TSX: DDD; BBSE: DRP) ("the Company") is pleased to announce that May 11, 2006 has been set as the date for the annual stockholder meeting of the Company. The annual meeting of Dragon stockholders will be held at Dragon's corporate offices at Suite 310, 650 West Georgia Street, Vancouver, Canada at 10:00 a.m. Pacific Time. Stockholders of Dragon of record as of the close of business on April 11, 2006 will be entitled to vote on the election of eight nominees as member of the Board of Directors to serve until their successors are elected and qualified. On or about April 13, 2006, the Company will send to these stockholders a copy of the definitive proxy statement in connection to the annual meeting. This press release contains forward looking statements. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward looking statements. Readers should not place undue reliance on forward looking statements, which only reflect the view of management as of the date hereof. The Company does not undertake the obligation to publicly revise these forward looking statements to reflect subsequent events or circumstances. Readers should carefully review the risk factors and other factors described in its periodic reports with the Securities and Exchange Commission. For further information please contact: Dragon Pharmaceutical Inc. Maggie Deng, COO Telephone: +1-(604)-669-8817 or North America Toll Free: 1-877-388-3784 Email: Website: http://www.dragonpharma.com/ DATASOURCE: Dragon Pharmaceutical Inc. CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, COO, Telephone: (604) 669-8817 or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/

Copyright

1 Year Bright Minds Biosciences Chart

1 Year Bright Minds Biosciences Chart

1 Month Bright Minds Biosciences Chart

1 Month Bright Minds Biosciences Chart